Influence of ARHGEF3 and RHOA knockdown on ACTA2 and other genes in osteoblasts and osteoclasts

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Mullin, Benjamin H ^a,b,c   Mamotte, Cyril ^b   Prince, Richard L ^a,c   Wilson, Scott G ^a,c,d  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; OSTEOPROTEGERIN; PARATHYROID HORMONE RECEPTOR 1; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1; SMALL INTERFERING RNA; ACTA2 PROTEIN, HUMAN; ACTIN; ARHGEF3 PROTEIN, HUMAN; PTH1R PROTEIN, HUMAN; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA PROTEIN, HUMAN;

ACTA2 GENE; ADULT; ARHGDIA GENE; ARHGEF3 GENE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE IDENTIFICATION; GENE SILENCING; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; OSTEOBLAST; OSTEOCLAST; PTH1R GENE; RHOA GENE; TNFRSF11B GENE; UPREGULATION; BONE DENSITY; CHROMOSOME 3; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; OSTEOPOROSIS; REAL TIME POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY;

ACTINS; BONE DENSITY; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICROARRAY ANALYSIS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; SPECTROPHOTOMETRY;

EID: 84901337504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098116     Document Type: Article

References (46)

1. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9: 1137-1141. (Pubitemid 24985932)
2. Prince RL, Dick I (1997) Oestrogen effects on calcium membrane transport: a new view of the inter-relationship between oestrogen deficiency and age-related osteoporosis. Osteoporos Int 7 Suppl 3: S150-154.
3. Flicker L, Hopper JL, Rodgers L, Kaymakci B, Green RM, et al. (1995) Bone density determinants in elderly women: a twin study. J Bone Miner Res 10: 1607-1613.
4. Michaelsson K, Melhus H, Ferm H, Ahlbom A, Pedersen NL (2005) Genetic liability to fractures in the elderly. Arch Intern Med 165: 1825-1830. (Pubitemid 41352076)
5. Evans RA, Marel GM, Lancaster EK, Kos S, Evans M, et al. (1988) Bone mass is low in relatives of osteoporotic patients. Ann Intern Med 109: 870-873. (Pubitemid 19000026)
6. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, et al. (1987) Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80: 706-710. (Pubitemid 18003941)
7. Seeman E, Hopper JL, Young NR, Formica C, Goss P, et al. (1996) Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study. Am J Physiol 270: E320-327.
8. Andrew T, Antioniades L, Scurrah KJ, Macgregor AJ, Spector TD (2005) Risk of wrist fracture in women is heritable and is influenced by genes that are largely independent of those influencing BMD. J Bone Miner Res 20: 67-74. (Pubitemid 41716220)
9. Deng HW, Chen WM, Recker S, Stegman MR, Li JL, et al. (2000) Genetic determination of Colles' fracture and differential bone mass in women with and without Colles' fracture. J Bone Miner Res 15: 1243-1252. (Pubitemid 30413856)
10. Ioannidis JP, Ng MY, Sham PC, Zintzaras E, Lewis CM, et al. (2007) Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J Bone Miner Res 22: 173-183. (Pubitemid 46167787)
11. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2006) Meta-analysis of genome-wide linkage studies for bone mineral density. J Hum Genet 51: 480-486. (Pubitemid 43863786)
12. Xiao P, Shen H, Guo YF, Xiong DH, Liu YZ, et al. (2006) Genomic regions identified for BMD in a large sample including epistatic interactions and gender-specific effects. J Bone Miner Res 21: 1536-1544. (Pubitemid 44484597)
13. Wilson SG, Reed PW, Bansal A, Chiano M, Lindersson M, et al. (2003) Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36. Am J Hum Genet 72: 144-155. (Pubitemid 36056850)
14. Wynne F, Drummond FJ, Daly M, Brown M, Shanahan F, et al. (2003) Suggestive linkage of 2p22-25 and 11q12-13 with low bone mineral density at the lumbar spine in the Irish population. Calcif Tissue Int 72: 651-658. (Pubitemid 36917318)
15. Mullin BH, Prince RL, Dick IM, Hart DJ, Spector TD, et al. (2008) Identification of a role for the ARHGEF3 gene in postmenopausal osteoporosis. Am J Hum Genet 82: 1262-1269.
16. Mullin BH, Prince RL, Mamotte C, Spector TD, Hart DJ, et al. (2009) Further genetic evidence suggesting a role for the RhoGTPase-RhoGEF pathway in osteoporosis. Bone 45: 387-391.
17. Arthur WT, Ellerbroek SM, Der CJ, Burridge K, Wennerberg K (2002) XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC. J Biol Chem 277: 42964-42972. (Pubitemid 35285675)
18. Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420: 629-635. (Pubitemid 36764489)
19. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS (2004) Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6: 483-495. (Pubitemid 38456178)
20. Meyers VE, Zayzafoon M, Douglas JT, McDonald JM (2005) RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity. J Bone Miner Res 20: 1858-1866. (Pubitemid 41361888)
21. Chellaiah MA, Soga N, Swanson S, McAllister S, Alvarez U, et al. (2000) Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem 275: 11993-12002. (Pubitemid 30237772)
22. Fogh J, Fogh JM, Orfeo T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59: 221-226. (Pubitemid 8144854)
23. Harris SA, Enger RJ, Riggs BL, Spelsberg TC (1995) Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10: 178-186.
24. Billiau A, Edy VG, Heremans H, Van Damme J, Desmyter J, et al. (1977) Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother 12: 11-15. (Pubitemid 8143077)
25. Backlund PS Jr (1997) Post-translational processing of RhoA. Carboxyl methylation of the carboxyl-terminal prenylcysteine increases the half-life of Rhoa. J Biol Chem 272: 33175-33180.
26. Illumina (2008) HumanHT-12 v3 Expression BeadChip. Illumina Technical Bulletin Pub. No.470-2008-005.
27. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
28. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108. (Pubitemid 351818697)
29. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193. (Pubitemid 36181903)
30. Illumina (2007) BeadStudio Normalization Algorithms for Gene Expression Data. Illumina Technical Bulletin Pub. No.470-2007-005.
31. Dunning MJ, Barbosa-Morais NL, Lynch AG, Tavare S, Ritchie ME (2008) Statistical issues in the analysis of Illumina data. BMC Bioinformatics 9: 85.
32. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society: Series B 57: 289-300.
33. Fatigati V, Murphy RA (1984) Actin and tropomyosin variants in smooth muscles. Dependence on tissue type. J Biol Chem 259: 14383-14388. (Pubitemid 15222253)
34. Owens GK (1995) Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517.
35. Mack CP, Somlyo AV, Hautmann M, Somlyo AP, Owens GK (2001) Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 276: 341-347. (Pubitemid 32050325)
36. Zhao XH, Laschinger C, Arora P, Szaszi K, Kapus A, et al. (2007) Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway. J Cell Sci 120: 1801-1809. (Pubitemid 46930418)
37. Pautke C, Schieker M, Tischer T, Kolk A, Neth P, et al. (2004) Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. Anticancer Res 24: 3743-3748. (Pubitemid 40468660)
38. Bilbe G, Roberts E, Birch M, Evans DB (1996) PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines. Bone 19: 437-445.
39. Subramaniam M, Jalal SM, Rickard DJ, Harris SA, Bolander ME, et al. (2002) Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB/ER alpha cells: bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridization. J Cell Biochem 87: 9-15. (Pubitemid 34969143)
40. Radeff JM, Nagy Z, Stern PH (2004) Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells. J Bone Miner Res 19: 1882-1891. (Pubitemid 41103440)
41. Wilkins TD, Lyerly DM (1996) Clostridium difficile toxins attack Rho. Trends Microbiol 4: 49-51. (Pubitemid 26077279)
42. Lowik CW, van der Pluijm G, Bloys H, Hoekman K, Bijvoet OL, et al. (1989) Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 162: 1546-1552. (Pubitemid 19214760)
43. Wang J, Stern PH (2010) Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Galpha(12) or constitutively active RhoA. J Cell Biochem.
44. DerMardirossian C, Bokoch GM (2005) GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 15: 356-363. (Pubitemid 40943524)
45. Fukumoto Y, Kaibuchi K, Hori Y, Fujioka H, Araki S, et al. (1990) Molecular cloning and characterization of a novel type of regulatory protein (GDI) for the rho proteins, ras p21-like small GTP-binding proteins. Oncogene 5: 1321-1328.
46. Olofsson B (1999) Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal 11: 545-554.